In addition, we found that lncRNA ATP2B1/miR-222-5p/TAB2 and lncRNA HUWE1/miR-222-5p/TAB2 are potential ceRNA regulatory networks in NSCLC drug resistance according to TCGA data and bioinformatics analysis. This evidence concerns the gene ATP2B1 and non-small cell lung carcinoma.